Dr Reddy's Laboratories Ltd said on Monday an independent board found Russia's Sputnik V COVID-19 vaccine to be safe in its mid-stage trial in India, and recommended progressing to late-stage trials.
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials, Dr.Reddy's said in a regulatory filing.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
COMMENTS
Advertisement
UK Covid-19 Inquiry To Issue First Report On Preparedness Joe Biden Tests Positive For Covid As Age Worries Mount Long Covid Symptoms To Last Longer In Pregnant Women: Study Why BJP Lost Lok Sabha Polls In Uttar Pradesh - 6 Reasons In Party Report Travel Influencer Aanvi Kamdar Dies After Falling Off A Waterfall Near Mumbai Puja Khedkar's Mother, Who Waved Gun At Farmers, In Police Custody More Than 40% Of Japanese Companies Have No Plan To Use AI: Reuters Poll "Unjustified": Russia On India Facing "Enormous Pressure" Due To Energy Ties Man Receives Worm-Infested Amul Buttermilk, Company Apologises Track Latest News Live on NDTV.com and get news updates from India and around the world.